Document is current
Any future updates will be listed below
-
Authors
Hwang, Byungjin
Lee, David S. https://orcid.org/0000-0001-6539-4272
Tamaki, Whitney
Sun, Yang https://orcid.org/0000-0002-9344-8060
Ogorodnikov, Anton
Hartoularos, George C.
Winters, Aidan https://orcid.org/0000-0001-8024-6155
Yeung, Bertrand Z.
Nazor, Kristopher L.
Song, Yun S. https://orcid.org/0000-0002-0734-9868
Chow, Eric D. https://orcid.org/0000-0001-8079-918X
Spitzer, Matthew H. https://orcid.org/0000-0002-5291-3819
Ye, Chun Jimmie https://orcid.org/0000-0001-6560-3783
- License Information
-
More Information
Article History
Received: 29 May 2020
Accepted: 24 June 2021
First Online: 5 August 2021
Competing interests
: C.J.Y. is a SAB member for and hold equity in Related Sciences and ImmunAI, a consultant for and hold equity in Maze Therapeutics and a consultant for Trex Bio. C.J.Y. has received research support from Chan Zuckerberg Initiative, Chan Zuckerberg Biohub and Genentech.
